Beijing Succeeder Technology Inc. (SHA:688338)

Market Cap	2.65B -7.6%
Revenue (ttm)	261.83M -4.8%
Net Income	84.45M -10.1%
EPS	0.80 -29.7%
Shares Out	103.97M
PE Ratio	31.85
Forward PE	n/a
Dividend	0.26 (1.02%)
Ex-Dividend Date	Jun 4, 2026

Volume	851,652
Open	26.19
Previous Close	25.89
Day's Range	25.45 - 26.19
52-Week Range	23.51 - 36.08
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHA:688338

Beijing Succeeder Technology Inc. engages in the research, development, production, and sales of testing instruments, reagents, and consumables in the field of in vitro diagnostics for thrombosis and hemostasis in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation rate and hematocrit testers, platelet aggregation testers, blood rheology analyzer, diagnostic reagents, and quality control products, as well as automated equipment with supporting testing instruments. Its products are u...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 268
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688338

Financial Performance

In 2025, SHA:688338's revenue was 263.24 million, a decrease of -13.94% compared to the previous year's 305.87 million. Earnings were 89.60 million, a decrease of -20.71%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error